Moving on to SMA patients, one study analyzed serum samples from 4 SMA patients and found a dramatic increase in the levels of circulating GDF-11, a decrease in the levels of circulating myostatin and a slight increase in circulating follistatin compared to patients with other neuromuscular diseases and controls [86]. The gene discussed is FST; the disease is proximal spinal muscular atrophy.